Renovos is a new regenerative medicine company capitalising on the decades of world-class orthopaedic research from the University of Southampton. Renovos will apply this knowledge to offer the wider orthopaedic research community new research tools, otherwise unavailable in the market, to develop the next generation of medicines, whilst supporting the development of our own novel therapeutic platform for safer, easier and more cost-effective bone repair. Serving universities, biotech and pharma, Renovos’s tools will include high-value human stem cells (unavailable elsewhere), disruptive new assay platforms and a rapid and high-throughput service to screen new drug compounds. In addition, Renovos is developing a proprietary drug delivery technology based on synthetic nanoclay-gels, with multiple medical applications. Clay-gels can be injected to the site of a fracture to accelerate tissue repair, through a controlled and localised release of therapeutic agents, offering a step-change in their safety and effectiveness.

Awarded the Faculty of Medicine Career Track award to pursue research and further funding opportunities for clay-nanoparticle mediated development of micro-environments for stem cells.

Lead research fellow, on a project developing ex vivo models of bone repair as part of the EU framework 7 ‘Biodesign’ consortium. The models developed will facilitate the reduction, refinement and replacement of animal testing in bone regeneration research programmes.

Funded by the University of Southampton to explore novel approaches to enriching mesenchymal stem cell populations from the bone marrow.

Lead research fellow working with clinicians and a global medical device company (Smith and Nephew Ltd.), to progress the clinical transition of a patented cell separation technology into a clinically effective and commercially viable surgical device

PDRA on a collaborative project at the interface of biology and maths aimed at dissecting the heterogeneity of bone marrow stromal cell (HBMSC) populations by characterising the migration and proliferation of their clonal units.